nodes	percent_of_prediction	percent_of_DWPC	metapath
Baclofen—SLC22A8—Pravastatin—atherosclerosis	0.395	1	CbGbCtD
Baclofen—Ibuprofen—THBD—atherosclerosis	0.00574	0.385	CrCbGaD
Baclofen—Ibuprofen—PLAT—atherosclerosis	0.00394	0.264	CrCbGaD
Baclofen—Ibuprofen—CXCL8—atherosclerosis	0.00181	0.121	CrCbGaD
Baclofen—Ibuprofen—PPARG—atherosclerosis	0.00125	0.0839	CrCbGaD
Baclofen—Chlorphenesin—PTGS2—atherosclerosis	0.00118	0.0794	CrCbGaD
Baclofen—Mediastinal disorder—Ezetimibe—atherosclerosis	0.00111	0.0026	CcSEcCtD
Baclofen—Alopecia—Lovastatin—atherosclerosis	0.00111	0.0026	CcSEcCtD
Baclofen—Myalgia—Rosuvastatin—atherosclerosis	0.0011	0.00258	CcSEcCtD
Baclofen—Flushing—Simvastatin—atherosclerosis	0.00109	0.00256	CcSEcCtD
Baclofen—Alopecia—Ezetimibe—atherosclerosis	0.00109	0.00255	CcSEcCtD
Baclofen—Rhinitis—Niacin—atherosclerosis	0.00108	0.00254	CcSEcCtD
Baclofen—GABBR2—GPCR ligand binding—CCL3—atherosclerosis	0.00108	0.00667	CbGpPWpGaD
Baclofen—Mental disorder—Ezetimibe—atherosclerosis	0.00108	0.00253	CcSEcCtD
Baclofen—Flatulence—Lovastatin—atherosclerosis	0.00108	0.00253	CcSEcCtD
Baclofen—Hypoaesthesia—Niacin—atherosclerosis	0.00108	0.00252	CcSEcCtD
Baclofen—Malnutrition—Ezetimibe—atherosclerosis	0.00107	0.00251	CcSEcCtD
Baclofen—Dysgeusia—Lovastatin—atherosclerosis	0.00107	0.00251	CcSEcCtD
Baclofen—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCG—atherosclerosis	0.00107	0.0066	CbGpPWpGaD
Baclofen—Rhinitis—Pravastatin—atherosclerosis	0.00107	0.0025	CcSEcCtD
Baclofen—Oedema peripheral—Niacin—atherosclerosis	0.00107	0.00249	CcSEcCtD
Baclofen—Confusional state—Rosuvastatin—atherosclerosis	0.00106	0.00249	CcSEcCtD
Baclofen—Back pain—Lovastatin—atherosclerosis	0.00106	0.00248	CcSEcCtD
Baclofen—Hypoaesthesia—Pravastatin—atherosclerosis	0.00106	0.00248	CcSEcCtD
Baclofen—Flatulence—Ezetimibe—atherosclerosis	0.00106	0.00248	CcSEcCtD
Baclofen—Chills—Simvastatin—atherosclerosis	0.00106	0.00247	CcSEcCtD
Baclofen—Infection—Rosuvastatin—atherosclerosis	0.00105	0.00245	CcSEcCtD
Baclofen—Visual impairment—Niacin—atherosclerosis	0.00104	0.00244	CcSEcCtD
Baclofen—GABBR1—G alpha (i) signalling events—CCR2—atherosclerosis	0.00104	0.00642	CbGpPWpGaD
Baclofen—Alopecia—Simvastatin—atherosclerosis	0.00104	0.00243	CcSEcCtD
Baclofen—Back pain—Ezetimibe—atherosclerosis	0.00104	0.00243	CcSEcCtD
Baclofen—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00103	0.00242	CcSEcCtD
Baclofen—Vision blurred—Lovastatin—atherosclerosis	0.00103	0.00242	CcSEcCtD
Baclofen—Mental disorder—Simvastatin—atherosclerosis	0.00103	0.00241	CcSEcCtD
Baclofen—Tremor—Lovastatin—atherosclerosis	0.00103	0.0024	CcSEcCtD
Baclofen—Visual impairment—Pravastatin—atherosclerosis	0.00103	0.0024	CcSEcCtD
Baclofen—GABBR1—GPCR ligand binding—CCL4—atherosclerosis	0.00102	0.00629	CbGpPWpGaD
Baclofen—Ill-defined disorder—Lovastatin—atherosclerosis	0.00102	0.00238	CcSEcCtD
Baclofen—Eye disorder—Niacin—atherosclerosis	0.00101	0.00236	CcSEcCtD
Baclofen—Flatulence—Simvastatin—atherosclerosis	0.00101	0.00236	CcSEcCtD
Baclofen—Tinnitus—Niacin—atherosclerosis	0.00101	0.00236	CcSEcCtD
Baclofen—Dysgeusia—Simvastatin—atherosclerosis	0.001	0.00235	CcSEcCtD
Baclofen—Flushing—Niacin—atherosclerosis	0.001	0.00235	CcSEcCtD
Baclofen—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000997	0.00233	CcSEcCtD
Baclofen—Anaemia—Ezetimibe—atherosclerosis	0.000993	0.00232	CcSEcCtD
Baclofen—Tinnitus—Pravastatin—atherosclerosis	0.000993	0.00232	CcSEcCtD
Baclofen—Malaise—Lovastatin—atherosclerosis	0.000988	0.00231	CcSEcCtD
Baclofen—Flushing—Pravastatin—atherosclerosis	0.000988	0.00231	CcSEcCtD
Baclofen—Cardiac disorder—Pravastatin—atherosclerosis	0.000988	0.00231	CcSEcCtD
Baclofen—Vertigo—Lovastatin—atherosclerosis	0.000985	0.0023	CcSEcCtD
Baclofen—Angiopathy—Niacin—atherosclerosis	0.000981	0.0023	CcSEcCtD
Baclofen—GABBR2—GPCR ligand binding—CCR2—atherosclerosis	0.000979	0.00603	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—EDNRA—atherosclerosis	0.000979	0.00603	CbGpPWpGaD
Baclofen—Chills—Niacin—atherosclerosis	0.00097	0.00227	CcSEcCtD
Baclofen—Malaise—Ezetimibe—atherosclerosis	0.000969	0.00227	CcSEcCtD
Baclofen—GABBR2—G alpha (i) signalling events—AGT—atherosclerosis	0.000967	0.00596	CbGpPWpGaD
Baclofen—Vision blurred—Simvastatin—atherosclerosis	0.000966	0.00226	CcSEcCtD
Baclofen—Arrhythmia—Niacin—atherosclerosis	0.000966	0.00226	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000961	0.00225	CcSEcCtD
Baclofen—Tremor—Simvastatin—atherosclerosis	0.00096	0.00225	CcSEcCtD
Baclofen—GABBR2—Neuronal System—PRKCG—atherosclerosis	0.000958	0.0059	CbGpPWpGaD
Baclofen—Alopecia—Niacin—atherosclerosis	0.000955	0.00224	CcSEcCtD
Baclofen—Chills—Pravastatin—atherosclerosis	0.000955	0.00223	CcSEcCtD
Baclofen—Insomnia—Rosuvastatin—atherosclerosis	0.000955	0.00223	CcSEcCtD
Baclofen—GABBR2—GPCR ligand binding—GHRL—atherosclerosis	0.000954	0.00587	CbGpPWpGaD
Baclofen—Ill-defined disorder—Simvastatin—atherosclerosis	0.000951	0.00223	CcSEcCtD
Baclofen—Arrhythmia—Pravastatin—atherosclerosis	0.000951	0.00223	CcSEcCtD
Baclofen—Palpitations—Ezetimibe—atherosclerosis	0.00095	0.00222	CcSEcCtD
Baclofen—Paraesthesia—Rosuvastatin—atherosclerosis	0.000948	0.00222	CcSEcCtD
Baclofen—Anaemia—Simvastatin—atherosclerosis	0.000947	0.00222	CcSEcCtD
Baclofen—Malnutrition—Niacin—atherosclerosis	0.000941	0.0022	CcSEcCtD
Baclofen—Alopecia—Pravastatin—atherosclerosis	0.000941	0.0022	CcSEcCtD
Baclofen—Chest pain—Lovastatin—atherosclerosis	0.000933	0.00218	CcSEcCtD
Baclofen—Myalgia—Lovastatin—atherosclerosis	0.000933	0.00218	CcSEcCtD
Baclofen—Anxiety—Lovastatin—atherosclerosis	0.00093	0.00218	CcSEcCtD
Baclofen—Dyspepsia—Rosuvastatin—atherosclerosis	0.000929	0.00217	CcSEcCtD
Baclofen—Hypertension—Ezetimibe—atherosclerosis	0.000928	0.00217	CcSEcCtD
Baclofen—Flatulence—Niacin—atherosclerosis	0.000927	0.00217	CcSEcCtD
Baclofen—Malaise—Simvastatin—atherosclerosis	0.000924	0.00216	CcSEcCtD
Baclofen—Discomfort—Lovastatin—atherosclerosis	0.000922	0.00216	CcSEcCtD
Baclofen—Vertigo—Simvastatin—atherosclerosis	0.000921	0.00215	CcSEcCtD
Baclofen—Chest pain—Ezetimibe—atherosclerosis	0.000915	0.00214	CcSEcCtD
Baclofen—Myalgia—Ezetimibe—atherosclerosis	0.000915	0.00214	CcSEcCtD
Baclofen—Flatulence—Pravastatin—atherosclerosis	0.000913	0.00214	CcSEcCtD
Baclofen—Dry mouth—Lovastatin—atherosclerosis	0.000912	0.00213	CcSEcCtD
Baclofen—GABBR1—GPCR ligand binding—UTS2—atherosclerosis	0.00091	0.0056	CbGpPWpGaD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000909	0.00213	CcSEcCtD
Baclofen—Dysgeusia—Pravastatin—atherosclerosis	0.000907	0.00212	CcSEcCtD
Baclofen—Discomfort—Ezetimibe—atherosclerosis	0.000904	0.00212	CcSEcCtD
Baclofen—Pain—Rosuvastatin—atherosclerosis	0.000902	0.00211	CcSEcCtD
Baclofen—Constipation—Rosuvastatin—atherosclerosis	0.000902	0.00211	CcSEcCtD
Baclofen—Confusional state—Lovastatin—atherosclerosis	0.000902	0.00211	CcSEcCtD
Baclofen—Dry mouth—Ezetimibe—atherosclerosis	0.000895	0.00209	CcSEcCtD
Baclofen—GABBR1—G alpha (i) signalling events—KNG1—atherosclerosis	0.000891	0.00549	CbGpPWpGaD
Baclofen—Infection—Lovastatin—atherosclerosis	0.000889	0.00208	CcSEcCtD
Baclofen—Vision blurred—Niacin—atherosclerosis	0.000887	0.00208	CcSEcCtD
Baclofen—Confusional state—Ezetimibe—atherosclerosis	0.000885	0.00207	CcSEcCtD
Baclofen—Vision blurred—Pravastatin—atherosclerosis	0.000873	0.00204	CcSEcCtD
Baclofen—Myalgia—Simvastatin—atherosclerosis	0.000873	0.00204	CcSEcCtD
Baclofen—Chest pain—Simvastatin—atherosclerosis	0.000873	0.00204	CcSEcCtD
Baclofen—GABBR1—GPCR ligand binding—CX3CR1—atherosclerosis	0.000872	0.00537	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—CASR—atherosclerosis	0.000872	0.00537	CbGpPWpGaD
Baclofen—Infection—Ezetimibe—atherosclerosis	0.000871	0.00204	CcSEcCtD
Baclofen—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00087	0.00203	CcSEcCtD
Baclofen—Anxiety—Simvastatin—atherosclerosis	0.00087	0.00203	CcSEcCtD
Baclofen—Tremor—Pravastatin—atherosclerosis	0.000868	0.00203	CcSEcCtD
Baclofen—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000863	0.00202	CcSEcCtD
Baclofen—Discomfort—Simvastatin—atherosclerosis	0.000862	0.00202	CcSEcCtD
Baclofen—Nervous system disorder—Ezetimibe—atherosclerosis	0.00086	0.00201	CcSEcCtD
Baclofen—Ill-defined disorder—Pravastatin—atherosclerosis	0.00086	0.00201	CcSEcCtD
Baclofen—Anaemia—Pravastatin—atherosclerosis	0.000857	0.002	CcSEcCtD
Baclofen—GABBR1—GPCR ligand binding—CX3CL1—atherosclerosis	0.000855	0.00527	CbGpPWpGaD
Baclofen—Anorexia—Lovastatin—atherosclerosis	0.000853	0.00199	CcSEcCtD
Baclofen—Skin disorder—Ezetimibe—atherosclerosis	0.000852	0.00199	CcSEcCtD
Baclofen—Vertigo—Niacin—atherosclerosis	0.000846	0.00198	CcSEcCtD
Baclofen—Syncope—Niacin—atherosclerosis	0.000844	0.00197	CcSEcCtD
Baclofen—Confusional state—Simvastatin—atherosclerosis	0.000844	0.00197	CcSEcCtD
Baclofen—Urticaria—Rosuvastatin—atherosclerosis	0.000838	0.00196	CcSEcCtD
Baclofen—GABBR2—GPCR ligand binding—KNG1—atherosclerosis	0.000837	0.00516	CbGpPWpGaD
Baclofen—Oedema—Simvastatin—atherosclerosis	0.000837	0.00196	CcSEcCtD
Baclofen—Malaise—Pravastatin—atherosclerosis	0.000836	0.00196	CcSEcCtD
Baclofen—Abdominal pain—Rosuvastatin—atherosclerosis	0.000834	0.00195	CcSEcCtD
Baclofen—Vertigo—Pravastatin—atherosclerosis	0.000833	0.00195	CcSEcCtD
Baclofen—GABBR2—GPCR ligand binding—AGTR1—atherosclerosis	0.000832	0.00513	CbGpPWpGaD
Baclofen—Palpitations—Niacin—atherosclerosis	0.000832	0.00195	CcSEcCtD
Baclofen—Infection—Simvastatin—atherosclerosis	0.000831	0.00194	CcSEcCtD
Baclofen—Loss of consciousness—Niacin—atherosclerosis	0.000827	0.00194	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000815	0.00191	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—CCL4—atherosclerosis	0.000813	0.00501	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—CNR2—atherosclerosis	0.000811	0.00499	CbGpPWpGaD
Baclofen—Insomnia—Lovastatin—atherosclerosis	0.000809	0.00189	CcSEcCtD
Baclofen—GABBR1—Transmission across Chemical Synapses—PRKCG—atherosclerosis	0.000806	0.00496	CbGpPWpGaD
Baclofen—Paraesthesia—Lovastatin—atherosclerosis	0.000803	0.00188	CcSEcCtD
Baclofen—Myalgia—Niacin—atherosclerosis	0.000801	0.00187	CcSEcCtD
Baclofen—Hypertension—Pravastatin—atherosclerosis	0.0008	0.00187	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000799	0.00187	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—HRH1—atherosclerosis	0.000798	0.00491	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—UTS2—atherosclerosis	0.000798	0.00491	CbGpPWpGaD
Baclofen—Anorexia—Simvastatin—atherosclerosis	0.000797	0.00187	CcSEcCtD
Baclofen—Dyspnoea—Lovastatin—atherosclerosis	0.000797	0.00187	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000796	0.00186	CcSEcCtD
Baclofen—Insomnia—Ezetimibe—atherosclerosis	0.000793	0.00186	CcSEcCtD
Baclofen—Myalgia—Pravastatin—atherosclerosis	0.000789	0.00185	CcSEcCtD
Baclofen—Chest pain—Pravastatin—atherosclerosis	0.000789	0.00185	CcSEcCtD
Baclofen—Paraesthesia—Ezetimibe—atherosclerosis	0.000788	0.00184	CcSEcCtD
Baclofen—Dyspepsia—Lovastatin—atherosclerosis	0.000787	0.00184	CcSEcCtD
Baclofen—Anxiety—Pravastatin—atherosclerosis	0.000786	0.00184	CcSEcCtD
Baclofen—Dry mouth—Niacin—atherosclerosis	0.000784	0.00183	CcSEcCtD
Baclofen—Dyspnoea—Ezetimibe—atherosclerosis	0.000782	0.00183	CcSEcCtD
Baclofen—Discomfort—Pravastatin—atherosclerosis	0.000779	0.00182	CcSEcCtD
Baclofen—Decreased appetite—Lovastatin—atherosclerosis	0.000777	0.00182	CcSEcCtD
Baclofen—Dyspepsia—Ezetimibe—atherosclerosis	0.000772	0.00181	CcSEcCtD
Baclofen—Fatigue—Lovastatin—atherosclerosis	0.000771	0.0018	CcSEcCtD
Baclofen—Oedema—Niacin—atherosclerosis	0.000768	0.0018	CcSEcCtD
Baclofen—GABBR2—GPCR downstream signaling—CASR—atherosclerosis	0.000765	0.00471	CbGpPWpGaD
Baclofen—Constipation—Lovastatin—atherosclerosis	0.000765	0.00179	CcSEcCtD
Baclofen—Pain—Lovastatin—atherosclerosis	0.000765	0.00179	CcSEcCtD
Baclofen—Confusional state—Pravastatin—atherosclerosis	0.000763	0.00178	CcSEcCtD
Baclofen—Decreased appetite—Ezetimibe—atherosclerosis	0.000763	0.00178	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000762	0.00178	CcSEcCtD
Baclofen—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000757	0.00177	CcSEcCtD
Baclofen—Asthenia—Rosuvastatin—atherosclerosis	0.000757	0.00177	CcSEcCtD
Baclofen—Insomnia—Simvastatin—atherosclerosis	0.000757	0.00177	CcSEcCtD
Baclofen—Oedema—Pravastatin—atherosclerosis	0.000756	0.00177	CcSEcCtD
Baclofen—Fatigue—Ezetimibe—atherosclerosis	0.000756	0.00177	CcSEcCtD
Baclofen—Shock—Niacin—atherosclerosis	0.000756	0.00177	CcSEcCtD
Baclofen—Infection—Pravastatin—atherosclerosis	0.000751	0.00176	CcSEcCtD
Baclofen—Paraesthesia—Simvastatin—atherosclerosis	0.000751	0.00176	CcSEcCtD
Baclofen—Constipation—Ezetimibe—atherosclerosis	0.00075	0.00176	CcSEcCtD
Baclofen—Pain—Ezetimibe—atherosclerosis	0.00075	0.00176	CcSEcCtD
Baclofen—Tachycardia—Niacin—atherosclerosis	0.00075	0.00175	CcSEcCtD
Baclofen—Pruritus—Rosuvastatin—atherosclerosis	0.000747	0.00175	CcSEcCtD
Baclofen—Skin disorder—Niacin—atherosclerosis	0.000746	0.00175	CcSEcCtD
Baclofen—Dyspnoea—Simvastatin—atherosclerosis	0.000746	0.00174	CcSEcCtD
Baclofen—GABBR1—G alpha (i) signalling events—CCL5—atherosclerosis	0.000745	0.00459	CbGpPWpGaD
Baclofen—Hyperhidrosis—Niacin—atherosclerosis	0.000743	0.00174	CcSEcCtD
Baclofen—Feeling abnormal—Lovastatin—atherosclerosis	0.000737	0.00172	CcSEcCtD
Baclofen—Dyspepsia—Simvastatin—atherosclerosis	0.000736	0.00172	CcSEcCtD
Baclofen—Anorexia—Niacin—atherosclerosis	0.000732	0.00171	CcSEcCtD
Baclofen—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000731	0.00171	CcSEcCtD
Baclofen—Hyperhidrosis—Pravastatin—atherosclerosis	0.000731	0.00171	CcSEcCtD
Baclofen—Decreased appetite—Simvastatin—atherosclerosis	0.000727	0.0017	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—HRH1—atherosclerosis	0.000725	0.00446	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—UTS2—atherosclerosis	0.000725	0.00446	CbGpPWpGaD
Baclofen—Feeling abnormal—Ezetimibe—atherosclerosis	0.000723	0.00169	CcSEcCtD
Baclofen—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000722	0.00169	CcSEcCtD
Baclofen—Diarrhoea—Rosuvastatin—atherosclerosis	0.000722	0.00169	CcSEcCtD
Baclofen—Fatigue—Simvastatin—atherosclerosis	0.000721	0.00169	CcSEcCtD
Baclofen—Anorexia—Pravastatin—atherosclerosis	0.000721	0.00169	CcSEcCtD
Baclofen—Hypotension—Niacin—atherosclerosis	0.000718	0.00168	CcSEcCtD
Baclofen—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000717	0.00168	CcSEcCtD
Baclofen—Constipation—Simvastatin—atherosclerosis	0.000715	0.00167	CcSEcCtD
Baclofen—Pain—Simvastatin—atherosclerosis	0.000715	0.00167	CcSEcCtD
Baclofen—GABBR2—GPCR downstream signaling—CNR2—atherosclerosis	0.000711	0.00438	CbGpPWpGaD
Baclofen—Urticaria—Lovastatin—atherosclerosis	0.000711	0.00166	CcSEcCtD
Baclofen—Abdominal pain—Lovastatin—atherosclerosis	0.000707	0.00165	CcSEcCtD
Baclofen—Body temperature increased—Lovastatin—atherosclerosis	0.000707	0.00165	CcSEcCtD
Baclofen—GABBR2—GPCR ligand binding—EDN1—atherosclerosis	0.000705	0.00435	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—CCL5—atherosclerosis	0.0007	0.00431	CbGpPWpGaD
Baclofen—Musculoskeletal discomfort—Niacin—atherosclerosis	0.0007	0.00164	CcSEcCtD
Baclofen—Dizziness—Rosuvastatin—atherosclerosis	0.000698	0.00163	CcSEcCtD
Baclofen—GABBR1—GPCR ligand binding—CCL3—atherosclerosis	0.000697	0.0043	CbGpPWpGaD
Baclofen—Urticaria—Ezetimibe—atherosclerosis	0.000697	0.00163	CcSEcCtD
Baclofen—Insomnia—Niacin—atherosclerosis	0.000695	0.00163	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—CX3CR1—atherosclerosis	0.000695	0.00428	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—CASR—atherosclerosis	0.000695	0.00428	CbGpPWpGaD
Baclofen—Body temperature increased—Ezetimibe—atherosclerosis	0.000693	0.00162	CcSEcCtD
Baclofen—Abdominal pain—Ezetimibe—atherosclerosis	0.000693	0.00162	CcSEcCtD
Baclofen—Paraesthesia—Niacin—atherosclerosis	0.00069	0.00161	CcSEcCtD
Baclofen—Feeling abnormal—Simvastatin—atherosclerosis	0.000689	0.00161	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000689	0.00161	CcSEcCtD
Baclofen—Dyspnoea—Niacin—atherosclerosis	0.000685	0.0016	CcSEcCtD
Baclofen—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000684	0.0016	CcSEcCtD
Baclofen—Insomnia—Pravastatin—atherosclerosis	0.000684	0.0016	CcSEcCtD
Baclofen—Somnolence—Niacin—atherosclerosis	0.000683	0.0016	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—CX3CL1—atherosclerosis	0.000681	0.0042	CbGpPWpGaD
Baclofen—Paraesthesia—Pravastatin—atherosclerosis	0.000679	0.00159	CcSEcCtD
Baclofen—Dyspepsia—Niacin—atherosclerosis	0.000676	0.00158	CcSEcCtD
Baclofen—Dyspnoea—Pravastatin—atherosclerosis	0.000674	0.00158	CcSEcCtD
Baclofen—Decreased appetite—Niacin—atherosclerosis	0.000668	0.00156	CcSEcCtD
Baclofen—Dyspepsia—Pravastatin—atherosclerosis	0.000666	0.00156	CcSEcCtD
Baclofen—Rash—Rosuvastatin—atherosclerosis	0.000665	0.00156	CcSEcCtD
Baclofen—Dermatitis—Rosuvastatin—atherosclerosis	0.000665	0.00156	CcSEcCtD
Baclofen—Urticaria—Simvastatin—atherosclerosis	0.000665	0.00155	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—HRH1—atherosclerosis	0.000664	0.00409	CbGpPWpGaD
Baclofen—Gastrointestinal disorder—Niacin—atherosclerosis	0.000663	0.00155	CcSEcCtD
Baclofen—Body temperature increased—Simvastatin—atherosclerosis	0.000661	0.00155	CcSEcCtD
Baclofen—Abdominal pain—Simvastatin—atherosclerosis	0.000661	0.00155	CcSEcCtD
Baclofen—Headache—Rosuvastatin—atherosclerosis	0.000661	0.00155	CcSEcCtD
Baclofen—Decreased appetite—Pravastatin—atherosclerosis	0.000657	0.00154	CcSEcCtD
Baclofen—Pain—Niacin—atherosclerosis	0.000657	0.00154	CcSEcCtD
Baclofen—Fatigue—Pravastatin—atherosclerosis	0.000652	0.00153	CcSEcCtD
Baclofen—Pain—Pravastatin—atherosclerosis	0.000647	0.00151	CcSEcCtD
Baclofen—Constipation—Pravastatin—atherosclerosis	0.000647	0.00151	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—CNR2—atherosclerosis	0.000646	0.00398	CbGpPWpGaD
Baclofen—Asthenia—Lovastatin—atherosclerosis	0.000642	0.0015	CcSEcCtD
Baclofen—Pruritus—Lovastatin—atherosclerosis	0.000633	0.00148	CcSEcCtD
Baclofen—GABBR1—GPCR ligand binding—CCR2—atherosclerosis	0.000631	0.00388	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—EDNRA—atherosclerosis	0.000631	0.00388	CbGpPWpGaD
Baclofen—GABBR2—G alpha (i) signalling events—CXCL8—atherosclerosis	0.00063	0.00388	CbGpPWpGaD
Baclofen—Asthenia—Ezetimibe—atherosclerosis	0.000629	0.00147	CcSEcCtD
Baclofen—Gastrointestinal pain—Niacin—atherosclerosis	0.000628	0.00147	CcSEcCtD
Baclofen—Nausea—Rosuvastatin—atherosclerosis	0.000627	0.00147	CcSEcCtD
Baclofen—Feeling abnormal—Pravastatin—atherosclerosis	0.000623	0.00146	CcSEcCtD
Baclofen—GABBR1—G alpha (i) signalling events—AGT—atherosclerosis	0.000623	0.00384	CbGpPWpGaD
Baclofen—Pruritus—Ezetimibe—atherosclerosis	0.000621	0.00145	CcSEcCtD
Baclofen—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000618	0.00145	CcSEcCtD
Baclofen—GABBR1—Neuronal System—PRKCG—atherosclerosis	0.000617	0.0038	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—GHRL—atherosclerosis	0.000615	0.00379	CbGpPWpGaD
Baclofen—Diarrhoea—Lovastatin—atherosclerosis	0.000612	0.00143	CcSEcCtD
Baclofen—Urticaria—Niacin—atherosclerosis	0.00061	0.00143	CcSEcCtD
Baclofen—Body temperature increased—Niacin—atherosclerosis	0.000607	0.00142	CcSEcCtD
Baclofen—Abdominal pain—Niacin—atherosclerosis	0.000607	0.00142	CcSEcCtD
Baclofen—Urticaria—Pravastatin—atherosclerosis	0.000601	0.00141	CcSEcCtD
Baclofen—Asthenia—Simvastatin—atherosclerosis	0.0006	0.0014	CcSEcCtD
Baclofen—Diarrhoea—Ezetimibe—atherosclerosis	0.0006	0.0014	CcSEcCtD
Baclofen—Abdominal pain—Pravastatin—atherosclerosis	0.000598	0.0014	CcSEcCtD
Baclofen—Body temperature increased—Pravastatin—atherosclerosis	0.000598	0.0014	CcSEcCtD
Baclofen—Pruritus—Simvastatin—atherosclerosis	0.000592	0.00138	CcSEcCtD
Baclofen—Dizziness—Lovastatin—atherosclerosis	0.000591	0.00138	CcSEcCtD
Baclofen—GABBR2—GPCR ligand binding—AGT—atherosclerosis	0.000586	0.00361	CbGpPWpGaD
Baclofen—Dizziness—Ezetimibe—atherosclerosis	0.00058	0.00136	CcSEcCtD
Baclofen—Diarrhoea—Simvastatin—atherosclerosis	0.000572	0.00134	CcSEcCtD
Baclofen—Vomiting—Lovastatin—atherosclerosis	0.000569	0.00133	CcSEcCtD
Baclofen—Rash—Lovastatin—atherosclerosis	0.000564	0.00132	CcSEcCtD
Baclofen—Dermatitis—Lovastatin—atherosclerosis	0.000563	0.00132	CcSEcCtD
Baclofen—SLC22A8—Transmembrane transport of small molecules—ABCG4—atherosclerosis	0.000563	0.00347	CbGpPWpGaD
Baclofen—Headache—Lovastatin—atherosclerosis	0.00056	0.00131	CcSEcCtD
Baclofen—Vomiting—Ezetimibe—atherosclerosis	0.000558	0.0013	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—CCL3—atherosclerosis	0.000555	0.00342	CbGpPWpGaD
Baclofen—Dizziness—Simvastatin—atherosclerosis	0.000553	0.00129	CcSEcCtD
Baclofen—Rash—Ezetimibe—atherosclerosis	0.000553	0.00129	CcSEcCtD
Baclofen—GABBR2—GPCR downstream signaling—EDNRA—atherosclerosis	0.000553	0.00341	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—CCR2—atherosclerosis	0.000553	0.00341	CbGpPWpGaD
Baclofen—Dermatitis—Ezetimibe—atherosclerosis	0.000553	0.00129	CcSEcCtD
Baclofen—Asthenia—Niacin—atherosclerosis	0.000551	0.00129	CcSEcCtD
Baclofen—Headache—Ezetimibe—atherosclerosis	0.00055	0.00129	CcSEcCtD
Baclofen—Pruritus—Niacin—atherosclerosis	0.000543	0.00127	CcSEcCtD
Baclofen—Asthenia—Pravastatin—atherosclerosis	0.000543	0.00127	CcSEcCtD
Baclofen—GABBR2—GPCR ligand binding—F2—atherosclerosis	0.000541	0.00333	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—ABCG8—atherosclerosis	0.00054	0.00332	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—KNG1—atherosclerosis	0.000539	0.00332	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—GHRL—atherosclerosis	0.000539	0.00332	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—AGTR1—atherosclerosis	0.000536	0.0033	CbGpPWpGaD
Baclofen—Pruritus—Pravastatin—atherosclerosis	0.000535	0.00125	CcSEcCtD
Baclofen—Vomiting—Simvastatin—atherosclerosis	0.000532	0.00124	CcSEcCtD
Baclofen—Nausea—Lovastatin—atherosclerosis	0.000531	0.00124	CcSEcCtD
Baclofen—Ibuprofen—PTGS2—atherosclerosis	0.000529	0.0354	CrCbGaD
Baclofen—Rash—Simvastatin—atherosclerosis	0.000527	0.00123	CcSEcCtD
Baclofen—Dermatitis—Simvastatin—atherosclerosis	0.000527	0.00123	CcSEcCtD
Baclofen—Diarrhoea—Niacin—atherosclerosis	0.000526	0.00123	CcSEcCtD
Baclofen—Headache—Simvastatin—atherosclerosis	0.000524	0.00123	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—CCL4—atherosclerosis	0.000524	0.00323	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—APOA4—atherosclerosis	0.000521	0.00321	CbGpPWpGaD
Baclofen—Nausea—Ezetimibe—atherosclerosis	0.000521	0.00122	CcSEcCtD
Baclofen—Diarrhoea—Pravastatin—atherosclerosis	0.000517	0.00121	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—UTS2—atherosclerosis	0.000514	0.00317	CbGpPWpGaD
Baclofen—Dizziness—Niacin—atherosclerosis	0.000508	0.00119	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—CCR2—atherosclerosis	0.000502	0.00309	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—EDNRA—atherosclerosis	0.000502	0.00309	CbGpPWpGaD
Baclofen—Dizziness—Pravastatin—atherosclerosis	0.0005	0.00117	CcSEcCtD
Baclofen—Nausea—Simvastatin—atherosclerosis	0.000497	0.00116	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—CASR—atherosclerosis	0.000493	0.00304	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—GHRL—atherosclerosis	0.000489	0.00301	CbGpPWpGaD
Baclofen—Vomiting—Niacin—atherosclerosis	0.000488	0.00114	CcSEcCtD
Baclofen—Rash—Niacin—atherosclerosis	0.000484	0.00113	CcSEcCtD
Baclofen—Dermatitis—Niacin—atherosclerosis	0.000484	0.00113	CcSEcCtD
Baclofen—GABBR2—GPCR ligand binding—CCL2—atherosclerosis	0.000482	0.00297	CbGpPWpGaD
Baclofen—Headache—Niacin—atherosclerosis	0.000481	0.00113	CcSEcCtD
Baclofen—Vomiting—Pravastatin—atherosclerosis	0.000481	0.00113	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—CCL4—atherosclerosis	0.00048	0.00296	CbGpPWpGaD
Baclofen—Rash—Pravastatin—atherosclerosis	0.000477	0.00112	CcSEcCtD
Baclofen—Dermatitis—Pravastatin—atherosclerosis	0.000476	0.00111	CcSEcCtD
Baclofen—Headache—Pravastatin—atherosclerosis	0.000474	0.00111	CcSEcCtD
Baclofen—GABBR2—GPCR downstream signaling—KNG1—atherosclerosis	0.000473	0.00291	CbGpPWpGaD
Baclofen—Ibuprofen—ALB—atherosclerosis	0.000471	0.0316	CrCbGaD
Baclofen—GABBR2—GPCR downstream signaling—AGTR1—atherosclerosis	0.00047	0.0029	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—UTS2—atherosclerosis	0.000467	0.00288	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—CNR2—atherosclerosis	0.000458	0.00282	CbGpPWpGaD
Baclofen—Nausea—Niacin—atherosclerosis	0.000456	0.00107	CcSEcCtD
Baclofen—GABBR1—GPCR ligand binding—EDN1—atherosclerosis	0.000455	0.0028	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—CCL5—atherosclerosis	0.000451	0.00278	CbGpPWpGaD
Baclofen—Nausea—Pravastatin—atherosclerosis	0.000449	0.00105	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—APOA2—atherosclerosis	0.000449	0.00276	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—CX3CR1—atherosclerosis	0.000448	0.00276	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—CASR—atherosclerosis	0.000448	0.00276	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—CX3CL1—atherosclerosis	0.000439	0.0027	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—KNG1—atherosclerosis	0.00043	0.00265	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HRH1—atherosclerosis	0.000428	0.00264	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—UTS2—atherosclerosis	0.000428	0.00264	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—AGTR1—atherosclerosis	0.000427	0.00263	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—ABCG1—atherosclerosis	0.000427	0.00263	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—CNR2—atherosclerosis	0.000416	0.00256	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CX3CR1—atherosclerosis	0.00041	0.00253	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CASR—atherosclerosis	0.00041	0.00253	CbGpPWpGaD
Baclofen—GABBR1—G alpha (i) signalling events—CXCL8—atherosclerosis	0.000406	0.0025	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CX3CL1—atherosclerosis	0.000402	0.00248	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—EDN1—atherosclerosis	0.000399	0.00246	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—CCL5—atherosclerosis	0.000396	0.00244	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	0.000387	0.00238	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CNR2—atherosclerosis	0.000381	0.00235	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—CXCL8—atherosclerosis	0.000381	0.00235	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—MMP3—atherosclerosis	0.000381	0.00234	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—AGT—atherosclerosis	0.000377	0.00232	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—PRKCG—atherosclerosis	0.000376	0.00232	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—EDN1—atherosclerosis	0.000362	0.00223	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—CCL5—atherosclerosis	0.000359	0.00221	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—CCL3—atherosclerosis	0.000358	0.0022	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—CCR2—atherosclerosis	0.000356	0.0022	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—EDNRA—atherosclerosis	0.000356	0.0022	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—F2—atherosclerosis	0.000349	0.00215	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—TRPV1—atherosclerosis	0.000348	0.00214	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—GHRL—atherosclerosis	0.000347	0.00214	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—PRKCG—atherosclerosis	0.000342	0.0021	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—VWF—atherosclerosis	0.00034	0.00209	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—APOC3—atherosclerosis	0.000338	0.00208	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—LDLR—atherosclerosis	0.000336	0.00207	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—APOA4—atherosclerosis	0.000336	0.00207	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—ABCG5—atherosclerosis	0.000335	0.00206	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—AGT—atherosclerosis	0.000331	0.00204	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CCL3—atherosclerosis	0.000328	0.00202	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—CCR2—atherosclerosis	0.000324	0.00199	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—EDNRA—atherosclerosis	0.000324	0.00199	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—GHRL—atherosclerosis	0.000315	0.00194	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—NCF1—atherosclerosis	0.000314	0.00194	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—CCL2—atherosclerosis	0.000311	0.00191	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CCL4—atherosclerosis	0.000309	0.00191	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—F2—atherosclerosis	0.000306	0.00188	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—KNG1—atherosclerosis	0.000305	0.00188	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—AGTR1—atherosclerosis	0.000303	0.00187	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—AGT—atherosclerosis	0.0003	0.00185	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CCR2—atherosclerosis	0.000297	0.00183	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—EDNRA—atherosclerosis	0.000297	0.00183	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CYBA—atherosclerosis	0.000295	0.00182	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000293	0.0018	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PARP1—atherosclerosis	0.000289	0.00178	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—GHRL—atherosclerosis	0.000289	0.00178	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—APOA2—atherosclerosis	0.000289	0.00178	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PLAT—atherosclerosis	0.000289	0.00178	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—F2—atherosclerosis	0.000278	0.00171	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—KNG1—atherosclerosis	0.000277	0.00171	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—UTS2—atherosclerosis	0.000276	0.0017	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—AGTR1—atherosclerosis	0.000275	0.00169	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—PIK3CG—atherosclerosis	0.000266	0.00164	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CX3CR1—atherosclerosis	0.000264	0.00163	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CASR—atherosclerosis	0.000264	0.00163	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CX3CL1—atherosclerosis	0.000259	0.0016	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—EDN1—atherosclerosis	0.000257	0.00158	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—CCL5—atherosclerosis	0.000255	0.00157	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—KNG1—atherosclerosis	0.000254	0.00156	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—AGTR1—atherosclerosis	0.000252	0.00155	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—CETP—atherosclerosis	0.000248	0.00153	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—CCL2—atherosclerosis	0.000247	0.00152	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PLG—atherosclerosis	0.000246	0.00151	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CNR2—atherosclerosis	0.000246	0.00151	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—CXCL8—atherosclerosis	0.000246	0.00151	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—MMP3—atherosclerosis	0.000245	0.00151	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—PRKCG—atherosclerosis	0.000242	0.00149	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—EDN1—atherosclerosis	0.000233	0.00144	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—SOCS3—atherosclerosis	0.000233	0.00143	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—CCL5—atherosclerosis	0.000231	0.00143	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MMP3—atherosclerosis	0.000225	0.00138	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—IGF2—atherosclerosis	0.000224	0.00138	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PRKCG—atherosclerosis	0.00022	0.00136	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—VWF—atherosclerosis	0.000219	0.00135	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—PLAT—atherosclerosis	0.000218	0.00135	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—APOC3—atherosclerosis	0.000218	0.00134	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—APOB—atherosclerosis	0.000217	0.00134	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—LDLR—atherosclerosis	0.000216	0.00133	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—CXCL8—atherosclerosis	0.000215	0.00133	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—EDN1—atherosclerosis	0.000214	0.00132	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—AGT—atherosclerosis	0.000213	0.00131	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CCL5—atherosclerosis	0.000212	0.00131	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CCL3—atherosclerosis	0.000211	0.0013	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—LPL—atherosclerosis	0.000207	0.00128	CbGpPWpGaD
Baclofen—SLC22A8—SLC-mediated transmembrane transport—ALB—atherosclerosis	0.000203	0.00125	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—NCF1—atherosclerosis	0.000202	0.00125	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PRKCG—atherosclerosis	0.000202	0.00124	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—F2—atherosclerosis	0.000197	0.00121	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—SPP1—atherosclerosis	0.000197	0.00121	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—CXCL8—atherosclerosis	0.000196	0.00121	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—AGT—atherosclerosis	0.000194	0.00119	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—EDNRA—atherosclerosis	0.000191	0.00118	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CCR2—atherosclerosis	0.000191	0.00118	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CYBA—atherosclerosis	0.00019	0.00117	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000189	0.00116	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PLAT—atherosclerosis	0.000186	0.00115	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PARP1—atherosclerosis	0.000186	0.00115	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—GHRL—atherosclerosis	0.000186	0.00115	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—PLG—atherosclerosis	0.000186	0.00114	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PDGFB—atherosclerosis	0.000182	0.00112	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—F2—atherosclerosis	0.000179	0.0011	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—AGT—atherosclerosis	0.000178	0.00109	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—LEP—atherosclerosis	0.000174	0.00107	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—APOE—atherosclerosis	0.000174	0.00107	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CAV1—atherosclerosis	0.000172	0.00106	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—APOA1—atherosclerosis	0.000172	0.00106	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—HMOX1—atherosclerosis	0.000171	0.00106	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PIK3CG—atherosclerosis	0.000171	0.00105	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—ESR1—atherosclerosis	0.000166	0.00102	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—APOB—atherosclerosis	0.000164	0.00101	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—F2—atherosclerosis	0.000164	0.00101	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—KNG1—atherosclerosis	0.000164	0.00101	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—AGTR1—atherosclerosis	0.000163	0.001	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—CCL2—atherosclerosis	0.000159	0.000982	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PLG—atherosclerosis	0.000158	0.000976	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PIK3CG—atherosclerosis	0.000157	0.000967	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—MAPK3—atherosclerosis	0.00015	0.000926	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—SOCS3—atherosclerosis	0.00015	0.000924	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—INS—atherosclerosis	0.000149	0.000915	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CCL2—atherosclerosis	0.000146	0.0009	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MMP3—atherosclerosis	0.000145	0.000892	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—IGF2—atherosclerosis	0.000144	0.000888	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—IGF1—atherosclerosis	0.000144	0.000885	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—APOB—atherosclerosis	0.00014	0.000863	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—CXCL8—atherosclerosis	0.000139	0.000855	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—PPARA—atherosclerosis	0.000138	0.000853	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—EDN1—atherosclerosis	0.000138	0.000849	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CCL5—atherosclerosis	0.000137	0.000842	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—SERPINE1—atherosclerosis	0.000136	0.000841	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—LPL—atherosclerosis	0.000134	0.000824	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—NOS3—atherosclerosis	0.00013	0.000803	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PRKCG—atherosclerosis	0.00013	0.000801	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—APOA1—atherosclerosis	0.00013	0.0008	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—SPP1—atherosclerosis	0.000127	0.00078	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—CXCL8—atherosclerosis	0.000126	0.000777	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PDGFB—atherosclerosis	0.000117	0.000722	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CXCL8—atherosclerosis	0.000116	0.000712	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—AGT—atherosclerosis	0.000114	0.000705	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—LEP—atherosclerosis	0.000112	0.00069	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—APOE—atherosclerosis	0.000112	0.00069	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—AKT1—atherosclerosis	0.000112	0.000688	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CAV1—atherosclerosis	0.000111	0.000684	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—APOA1—atherosclerosis	0.000111	0.000682	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—IL6—atherosclerosis	0.00011	0.000677	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—ESR1—atherosclerosis	0.000107	0.000659	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—F2—atherosclerosis	0.000106	0.000651	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MMP9—atherosclerosis	0.000105	0.000644	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—NFKB1—atherosclerosis	0.000103	0.000637	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—ALB—atherosclerosis	0.000103	0.000634	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MAPK8—atherosclerosis	0.000102	0.000626	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—AKT1—atherosclerosis	0.000101	0.000625	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PIK3CG—atherosclerosis	0.000101	0.000623	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—MAPK3—atherosclerosis	9.69e-05	0.000597	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—INS—atherosclerosis	9.57e-05	0.00059	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CCL2—atherosclerosis	9.42e-05	0.00058	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—VEGFA—atherosclerosis	9.39e-05	0.000578	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—STAT3—atherosclerosis	9.29e-05	0.000573	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—IGF1—atherosclerosis	9.26e-05	0.00057	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MAPK3—atherosclerosis	8.88e-05	0.000547	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—SERPINE1—atherosclerosis	8.79e-05	0.000542	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—TGFB1—atherosclerosis	8.62e-05	0.000531	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—NOS3—atherosclerosis	8.4e-05	0.000517	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CXCL8—atherosclerosis	7.45e-05	0.000459	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—AKT1—atherosclerosis	7.19e-05	0.000443	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—IL6—atherosclerosis	7.08e-05	0.000436	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MMP9—atherosclerosis	6.74e-05	0.000415	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—NFKB1—atherosclerosis	6.67e-05	0.000411	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MAPK8—atherosclerosis	6.55e-05	0.000404	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—AKT1—atherosclerosis	6.53e-05	0.000402	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—IL6—atherosclerosis	6.49e-05	0.0004	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—VEGFA—atherosclerosis	6.05e-05	0.000373	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—AKT1—atherosclerosis	5.99e-05	0.000369	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—STAT3—atherosclerosis	5.99e-05	0.000369	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MAPK3—atherosclerosis	5.72e-05	0.000352	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—TGFB1—atherosclerosis	5.55e-05	0.000342	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—IL6—atherosclerosis	4.18e-05	0.000258	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—AKT1—atherosclerosis	3.86e-05	0.000238	CbGpPWpGaD
